Diagnosis of human cytomegalovirus disease

Clinical Microbiology Newsletter

Volumn 22, Issue 14, 2000, Pages 105-109

  Yen Lieberman, Belinda ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ASSAY; CELL CULTURE; CYTOMEGALIC INCLUSION BODY DISEASE; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DNA DETERMINATION; FOOD AND DRUG ADMINISTRATION; GENE AMPLIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; HYBRIDIZATION; IMMUNOFLUORESCENCE TEST; LABORATORY DIAGNOSIS; REVIEW; STANDARDIZATION; VIREMIA; VIRUS CULTURE; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TITRATION;

EID: 0034660995     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(00)80001-X     Document Type: Article

References (42)

1. Newer methods for diagnosis of cytomegalovirus infections
2. Virologic and pathogenetic aspects of cytomegalovirus infections
3. Cytomegalovirus infection of breast milk and transmission in infancy
4. Maternal cytomegalovirus excretion and perinatal infection
5. Summary of a workshop on surveillance for congenital cytomegalovirus disease
6. Cytomegalovirus
7. Cytomegalovirus revisited
8. Improved diagnosis of cytomegalovirus infection by detection of antigenemia or use of PCR methods
9. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet irradiated human cytomegalovirus
10. Cytomegalovirus and cancer of the prostate: In vitro transformation of human cells
11. Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection
12. Cytomegalovirus infections in organ transplant recipients
13. Preemptive therapy in immunocompromised patients
14. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood
15. Current approaches to the prevention and treatment of cytomegalovirus disease after bone marrow transplantation: An overview
16. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens
17. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection
18. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia
19. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical diseases
20. Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection
21. The cytomegalovirus antigenemia assay: A plea for standardization
22. Multicenter comparison of the Digene Hybrid Capture CMV DNA Assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia
23. Novel DNA assay for cytomegalovirus detection: Comparison with conventional culture and pp65 antigenemia assay
24. Surveillance of cytomegalovirus after solid-organ transplantation: Comparison of pp65 antigenemia assay with a quantitative DNA hybridization assay
25. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplanatation
26. A onetube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes
27. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renalallograft recipients by nucleic acid sequence-based amplification
28. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification
29. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients
30. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients
31. Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification
32. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma
33. A prospective comparison of molecular diagnostics techniques for the early detection of cytomegalovirus in liver transplant recipients
34. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease
35. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis
36. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes
37. Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation
38. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis